New patent for Bioxcel drug IGALMI

Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug. This drug has sixty-five patent family members in sixteen countries. The generic ingredient in IGALMI is dexmedetomidine hydrochloride. One supplier is listed for […]

Source